Loading clinical trials...
Loading clinical trials...
Early Detection of Fabry Disease (FD): Using Real-World Data for the Development of Advanced Natural Language Processing Methods: Retrospective Database Analysis
Conditions
Interventions
No intervention
Locations
3
Germany
Universitätsklinikum Erlangen Kinder- und Jugendklinik
Erlangen, Germany
Universitätsklinikum Erlangen Neurologische Klinik
Erlangen, Germany
Universitätsklinikum Giessen
Giessen, Germany
Start Date
November 30, 2023
Primary Completion Date
December 16, 2025
Completion Date
December 16, 2025
Last Updated
March 16, 2026
NCT06941025
NCT07382128
NCT05923788
NCT05473637
NCT07277361
NCT04252066
Lead Sponsor
Takeda
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions